CANNABIS INVESTMENTS

CPH set to expand in $300M Latin American CBD market

Finfeed Archived Jun 04, 2021

The expansion of its comprehensive distribution agreement with leading nutritional supplements company Route2 Pharm Pvt Ltd, will allow for distribution of Creso Pharma Limited's (ASX: CPH, FRA: 1X8) hemp derived therapeutic products sold under the cannaQIX® and CannaDOL brands into Ecuador.

CPH looks to expand its footprint as NY State reaches deal legalise recreational cannabis

Finfeed Archived Apr 06, 2021

Creso Pharma (ASX: CPH) has appointed a US Director of Business Development just as New York State has legalised recreational cannabis. New York State is expected to become one of the largest recreational markets in the US valued at US$4.2BN.

Roots widens cannabis footprint in California

Finfeed Archived Dec 11, 2020

Roots Sustainable Agricultural Technologies Limited (ASX: ROO) has secured a Non-binding Letter of Intent (LOI) with smart technology provider, Humboldt CCTV to integrate its proprietary Root Zone Temperature Optimisation (RZTO) technology and revolutionary heat exchange stub product into Humboldt’s Smart Agriculture solution.

More streamlined Harvest One to offer MMJ improved returns

Finfeed Archived Jun 29, 2020

MMJ Group investee company, Harvest One Cannabis, has restructured its business with a view to delivering improved returns.

Podcast: The future of the cannabis industry and what investors should expect

Finfeed Archived May 27, 2020

Here to speak with Finfeed today about the ups and downs of the cannabis industry, cannabis in Canada and what he sees is the future of the cannabis industry is COO and director of Embark Health, Mike Curtis.

MMJ Group upbeat about Embark Health’s first B2B sale

Finfeed Archived May 11, 2020

MMJ investee Embark Health has signed the group’s first business to business (B2B) sale of Bulk Bubble Hash.

Will 2021 be the year the cannabis industry makes a comeback?

Finfeed Archived May 08, 2020

The bubble has officially burst when it comes to the global cannabis market, yet it seems increasingly likely that 2021 will be a rebound year industry — once the coronavirus pandemic eases and markets begin to rally — but the path to profitability won't be easy.

MMJ Emerging from the Storm as Cannabis 2.0 Gathers Momentum

Next Investors Archived Apr 09, 2020

MMJ Group (ASX: MMJ) scours the globe evaluating the best opportunities in cannabis and is quietly amassing positions at discounted prices right now, as the sector is considered out of favour.